AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 13,214
-220 (-1.64%)
Jun 2, 2026, 4:53 PM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 208.36 billion as of June 2, 2026. Its market cap has increased by 28.98% in one year.
Market Cap
208.36B
Enterprise Value
228.36B
Revenue
45.77B
Ranking
n/a
PE Ratio
26.72
Stock Price
13,214.00
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 208.36B, an increase of 4,478.95%. That is a compound annual growth rate of 12.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 208.36B | -2.56% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 75.11B |
| Haleon | 29.83B |
| Smith & Nephew | 9.49B |
| Convatec Group | 3.95B |
| Hikma Pharmaceuticals | 3.14B |
| Genus | 1.56B |
| HUTCHMED (China) | 1.50B |
| Oxford Nanopore Technologies | 1.39B |